KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Common Equity: 2017-2025

Historic Common Equity for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to $473.0 million.

  • Twist Bioscience's Common Equity rose 0.06% to $473.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $473.0 million, marking a year-over-year increase of 0.06%. This contributed to the annual value of $473.0 million for FY2025, which is 0.06% up from last year.
  • Twist Bioscience's Common Equity amounted to $473.0 million in FY2025, which was up 0.06% from $472.7 million recorded in FY2024.
  • Twist Bioscience's Common Equity's 5-year high stood at $789.4 million during FY2022, with a 5-year trough of $472.7 million in FY2024.
  • For the 3-year period, Twist Bioscience's Common Equity averaged around $523.0 million, with its median value being $473.0 million (2025).
  • Its Common Equity has fluctuated over the past 5 years, first surged by 72.73% in 2021, then fell by 24.18% in 2024.
  • Twist Bioscience's Common Equity (Yearly) stood at $580.8 million in 2021, then spiked by 35.91% to $789.4 million in 2022, then declined by 21.02% to $623.4 million in 2023, then declined by 24.18% to $472.7 million in 2024, then climbed by 0.06% to $473.0 million in 2025.